Clinical characteristics of elderly depressive patients with low metaiodobenzylguanidine uptake

Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society
Shintaro TakenoshitaNorihito Yamada

Abstract

Recently, depression with Lewy body pathology before the appearance of parkinsonism and cognitive dysfunction has been drawing attention. Low cardiac metaiodobenzylguanidine (MIBG) uptake is helpful for early differentiation of Lewy body disease (LBD) from late-onset psychiatric disorders even before parkinsonism or dementia appears. In this study, we used MIBG uptake as a tool in suspected LBD, and evaluated the relationship of MIBG results to clinical characteristics and depressive symptoms. Fifty-two elderly inpatients with depression were included in this study. The Hamilton Depression Rating Scale (HDRS) was administered at admission, and 123 I-MIBG cardiac scintigraphy was performed. Of 52 patients, 38 had normal and 14 had reduced MIBG uptake. Correlation analyses of the late phase heart-to-mediastinum (H/M) ratio on the MIBG test and each item of the HDRS revealed that the H/M ratio was significantly correlated with scores of 'agitation', 'anxiety-somatic', and 'retardation' on the HDRS. Mean HDRS composite scores of 'somatic and psychic anxiety (Marcos)' and 'somatic anxiety/somatization factor (Pancheri)' were higher in the low uptake group than in the normal uptake group. Elderly patients with depression who manifest...Continue Reading

References

Aug 1, 1990·Acta Psychiatrica Scandinavica·T Marcos, M Salamero
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Sep 9, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert A SweetCharles F Reynolds
Sep 2, 2005·The American Journal of Psychiatry·Alex J Mitchell, Hari Subramaniam
Mar 14, 2007·Neurology·C F LippaUNKNOWN DLB/PDD Working Group
Jul 17, 2009·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Sho TakahashiTakashi Asada
Nov 26, 2010·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Koichi OkudaSeigo Kinuya
Feb 2, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Christos TsopelasUNKNOWN Medical Research Council Cognitive Function and Ageing Study
Sep 29, 2011·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Yumiko YamaneKiyoshi Maeda
Dec 27, 2011·Nature Reviews. Neurology·Dag AarslandPer Svenningsson
Jun 26, 2013·Pharmacotherapy·Jack J Chen, Laura Marsh
Aug 6, 2013·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Hiroshige FujishiroKiyoshi Sato
Oct 18, 2013·JAMA Psychiatry·Robert S WilsonDavid A Bennett
Feb 4, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Alex IranzoJoan Santamaria
Nov 6, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Kathy DujardinLuc Defebvre
Jan 6, 2015·Parkinsonism & Related Disorders·Sonja RuttenOdile A van den Heuvel
Aug 3, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Koji KasanukiHeii Arai
Jan 25, 2018·Psychological Medicine·Paul C DonaghyAlan J Thomas
Mar 13, 2018·Journal of Geriatric Psychiatry and Neurology·Martinus P G BroenG M Pontone
Aug 15, 2018·Alzheimer Disease and Associated Disorders·Janina Krell-RoeschYonas E Geda

❮ Previous
Next ❯

Citations

Nov 30, 2019·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Kurt SegersMurielle Surquin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.